MeSH term
Frequency | Condition_Probility | Humans | 120 | 0.0 |
Animals | 88 | 0.0 |
Aquaporins/*genetics/*metabolism | 4 | 57.0 |
Kidney/*physiology | 4 | 9.0 |
Kidney Concentrating Ability/*physiology | 2 | 40.0 |
Mice | 15 | 0.0 |
Mice, Transgenic | 4 | 0.0 |
6-Ketoprostaglandin F1 alpha/urine | 2 | 50.0 |
Adult | 21 | 0.0 |
Aquaporins/*urine | 10 | 50.0 |
Female | 37 | 0.0 |
Male | 39 | 0.0 |
Osmolar Concentration | 18 | 2.0 |
Aquaporins/*genetics | 7 | 41.0 |
Asian Continental Ancestry Group/*genetics | 2 | 0.0 |
DNA Mutational Analysis | 6 | 0.0 |
Immunoblotting | 8 | 0.0 |
Immunohistochemistry | 13 | 0.0 |
Osmosis | 3 | 11.0 |
Permeability | 5 | 3.0 |
Research Support, Non-U.S. Gov't | 85 | 0.0 |
Water/metabolism | 16 | 23.0 |
Amino Acid Sequence | 26 | 0.0 |
Aquaporins/*genetics/metabolism | 4 | 50.0 |
Base Sequence | 14 | 0.0 |
Cell Membrane/metabolism | 9 | 0.0 |
Cells, Cultured | 3 | 0.0 |
Desmopressin/pharmacology | 4 | 11.0 |
Dogs | 4 | 0.0 |
Endosomes/*metabolism | 2 | 1.0 |
Molecular Sequence Data | 28 | 0.0 |
Oocytes | 3 | 2.0 |
Point Mutation | 5 | 0.0 |
Renal Agents/pharmacology | 3 | 37.0 |
Sequence Deletion | 3 | 0.0 |
Child | 9 | 0.0 |
Desmopressin/*therapeutic use | 2 | 6.0 |
Diabetes Insipidus, Nephrogenic/*genetics | 9 | 64.0 |
Pedigree | 15 | 0.0 |
Chromosomes, Human, Pair 12/genetics | 3 | 3.0 |
Mutation | 8 | 0.0 |
Aquaporins/genetics/*metabolism | 4 | 18.0 |
Cell Line | 14 | 0.0 |
Gene Expression | 3 | 0.0 |
Microscopy, Confocal | 2 | 0.0 |
Microscopy, Immunoelectron | 6 | 1.0 |
Rats | 27 | 0.0 |
Transfection | 12 | 0.0 |
Diagnosis, Differential | 2 | 0.0 |
Genes, Recessive | 4 | 0.0 |
Genotype | 3 | 0.0 |
Linkage (Genetics) | 2 | 0.0 |
Phenotype | 3 | 0.0 |
Vasopressins/physiology | 2 | 20.0 |
X Chromosome | 2 | 0.0 |
Aquaporins/chemistry/*genetics/*metabolism | 3 | 75.0 |
Argipressin/pharmacology | 4 | 8.0 |
Cell Fractionation | 2 | 0.0 |
Cell Membrane/*metabolism | 3 | 1.0 |
Forskolin/pharmacology | 3 | 0.0 |
Kidney/cytology | 2 | 1.0 |
Protein Structure, Tertiary | 4 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 27 | 0.0 |
Heterozygote | 3 | 0.0 |
Kidney/metabolism | 3 | 0.0 |
Lung/metabolism | 3 | 1.0 |
*Membrane Proteins | 6 | 0.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
Rats, Wistar | 4 | 0.0 |
Skin/metabolism | 2 | 1.0 |
Subcellular Fractions | 2 | 1.0 |
Body Water/metabolism | 3 | 9.0 |
Molecular Conformation | 2 | 0.0 |
Signal Transduction | 4 | 0.0 |
Aldosterone/blood | 2 | 1.0 |
Angiotensin II/blood | 2 | 3.0 |
Argipressin/blood | 3 | 2.0 |
Blood Pressure | 2 | 0.0 |
Middle Aged | 9 | 0.0 |
Reference Values | 8 | 0.0 |
Sodium/urine | 2 | 3.0 |
Urine | 5 | 12.0 |
Aged | 5 | 0.0 |
Aquaporins/urine | 2 | 66.0 |
Water/*metabolism | 10 | 21.0 |
Blotting, Western | 6 | 0.0 |
Cell Membrane Permeability | 4 | 2.0 |
Child, Preschool | 5 | 0.0 |
Infant | 3 | 0.0 |
Oocytes/metabolism | 8 | 4.0 |
Xenopus laevis | 9 | 2.0 |
DNA, Complementary/metabolism | 4 | 0.0 |
Protein Conformation | 7 | 0.0 |
Time Factors | 9 | 0.0 |
Urea/pharmacology | 2 | 5.0 |
Atrial Natriuretic Factor/blood | 3 | 3.0 |
Diuresis/*physiology | 2 | 25.0 |
Receptors, Vasopressin/*physiology | 2 | 40.0 |
Vasopressins/*physiology | 2 | 11.0 |
*Adaptor Proteins, Signal Transducing | 2 | 0.0 |
Aquaporins/*metabolism | 11 | 34.0 |
Kidney/*metabolism | 4 | 2.0 |
Rats, Sprague-Dawley | 5 | 0.0 |
*Evolution, Molecular | 2 | 0.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
Cell Membrane/chemistry | 2 | 1.0 |
In Vitro | 4 | 0.0 |
Aquaporins/*physiology | 4 | 57.0 |
Kinetics | 6 | 0.0 |
Models, Molecular | 5 | 0.0 |
*Mutation, Missense | 4 | 0.0 |
Protein Structure, Secondary | 2 | 0.0 |
Infusions, Intravenous | 2 | 0.0 |
Receptors, Vasopressin/*genetics | 5 | 20.0 |
Diabetes Insipidus, Nephrogenic/*genetics/metabolism | 6 | 75.0 |
English Abstract | 5 | 0.0 |
*Mutation | 8 | 0.0 |
X Chromosome/genetics | 2 | 1.0 |
*Membrane Glycoproteins | 3 | 0.0 |
Aquaporins/genetics | 3 | 60.0 |
Circadian Rhythm | 2 | 0.0 |
Disease Models, Animal | 3 | 0.0 |
Promoter Regions (Genetics) | 3 | 0.0 |
Swine | 3 | 0.0 |
Diuresis/*drug effects | 2 | 15.0 |
*Genes, Recessive | 2 | 1.0 |
Sodium/metabolism | 2 | 1.0 |
Argipressin/*physiology | 2 | 8.0 |
Dehydration/urine | 2 | 100.0 |
Cloning, Molecular | 7 | 0.0 |
Tissue Distribution | 5 | 0.0 |
Vasopressins/blood | 2 | 9.0 |
Water-Electrolyte Balance/*physiology | 5 | 14.0 |
Adolescent | 7 | 0.0 |
Digestive Physiology | 2 | 8.0 |
Vasopressins/metabolism | 6 | 35.0 |
Biological Transport | 3 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
Kidney Tubules, Proximal/metabolism | 2 | 14.0 |
Mutagenesis, Site-Directed | 5 | 0.0 |
Xenopus | 7 | 1.0 |
Aquaporins/*biosynthesis/*chemistry/drug effects | 2 | 100.0 |
CHO Cells | 4 | 0.0 |
Cholic Acids/pharmacology | 2 | 15.0 |
Detergents/pharmacology | 2 | 1.0 |
Diabetes Insipidus, Nephrogenic/*metabolism | 3 | 100.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Endopeptidase K/pharmacology | 2 | 33.0 |
Endoplasmic Reticulum/metabolism | 3 | 1.0 |
Glycerol/pharmacology | 2 | 18.0 |
Hamsters | 5 | 0.0 |
Octoxynol/pharmacology | 2 | 3.0 |
Protein Folding | 2 | 0.0 |
Thermolysin/pharmacology | 2 | 50.0 |
Frameshift Mutation | 4 | 1.0 |
Prognosis | 2 | 0.0 |
Blotting, Northern | 4 | 0.0 |
Polymerase Chain Reaction | 5 | 0.0 |
RNA, Messenger/analysis | 3 | 0.0 |
Kidney/*metabolism/ultrastructure | 2 | 50.0 |
Osmosis/drug effects | 2 | 66.0 |
Vasopressins/pharmacology | 2 | 12.0 |
Conserved Sequence | 2 | 0.0 |
DNA, Complementary | 2 | 0.0 |
Exons | 2 | 0.0 |
Introns | 2 | 0.0 |
*Multigene Family | 2 | 0.0 |
Models, Biological | 2 | 0.0 |
Comparative Study | 4 | 0.0 |
Body Water/*metabolism | 3 | 13.0 |
Pregnancy | 2 | 0.0 |
Diabetes Insipidus, Nephrogenic/metabolism | 2 | 100.0 |
Aquaporins/physiology | 2 | 50.0 |
Receptors, Vasopressin/physiology | 2 | 66.0 |
Protein Binding | 2 | 0.0 |
Kidney Tubules, Collecting/physiology | 2 | 66.0 |
Mutation/genetics | 2 | 0.0 |
Body Water/*physiology | 2 | 28.0 |
Diabetes Insipidus, Nephrogenic/physiopathology | 2 | 100.0 |
Organ Specificity | 2 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Down-Regulation | 2 | 0.0 |
*Aquaporins | 34 | 44.0 |
Infant, Newborn | 3 | 0.0 |
Ion Channels/*metabolism | 2 | 4.0 |
Phosphorylation | 7 | 0.0 |
Epithelial Cells/metabolism | 2 | 0.0 |
Kidney Tubules, Collecting/*metabolism | 2 | 33.0 |
Diabetes Insipidus, Nephrogenic/*genetics/*metabolism | 2 | 100.0 |
Ion Channels/*genetics/*metabolism | 2 | 28.0 |
Glycerol/metabolism | 2 | 5.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Case-Control Studies | 2 | 0.0 |
Drug Resistance | 2 | 0.0 |
Mercuric Chloride/*pharmacology | 2 | 40.0 |
Genes, Structural | 2 | 0.0 |
Kidney Tubules, Collecting/metabolism | 2 | 33.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Ion Channels/*genetics | 9 | 20.0 |
Radioimmunoassay | 2 | 0.0 |
Chromosome Mapping | 4 | 0.0 |
Restriction Mapping | 3 | 0.0 |
Family Health | 2 | 0.0 |
Brain/metabolism | 2 | 0.0 |
Eye/metabolism | 2 | 14.0 |
Cyclic AMP/metabolism | 3 | 0.0 |
*Point Mutation | 2 | 0.0 |
Water-Electrolyte Balance/physiology | 2 | 5.0 |
Gene Expression Regulation, Developmental | 2 | 0.0 |
Water-Electrolyte Balance | 2 | 3.0 |
Protein Transport | 4 | 0.0 |
Base Sequence/genetics | 2 | 0.0 |
Chromosome Banding | 2 | 0.0 |
*Chromosomes, Human, Pair 12 | 2 | 0.0 |
Membrane Proteins/*genetics | 2 | 0.0 |
DNA Primers | 2 | 0.0 |
Oocytes/physiology | 2 | 1.0 |
Retrospective Studies | 2 | 0.0 |
Sodium-Potassium-Chloride Symporters/genetics/*metabolism | 2 | 66.0 |
Kidney Concentrating Ability/physiology | 2 | 25.0 |
Microscopy, Fluorescence | 2 | 0.0 |
Intracellular Membranes/metabolism | 2 | 1.0 |
*Water-Electrolyte Balance | 2 | 4.0 |
Creatinine/urine | 3 | 2.0 |
